abiraterone acetate

Generic: abiraterone acetate

Labeler: major pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abiraterone acetate
Generic Name abiraterone acetate
Labeler major pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

abiraterone acetate 250 mg/1

Manufacturer
Major Pharmaceuticals

Identifiers & Regulatory

Product NDC 0904-6948
Product ID 0904-6948_d8b7c351-b030-4655-94af-f88ad6c5bd12
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208453
Listing Expiration 2026-12-31
Marketing Start 2018-11-23

Pharmacologic Class

Classes
cytochrome p450 17a1 inhibitor [epc] cytochrome p450 17a1 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 09046948
Hyphenated Format 0904-6948

Supplemental Identifiers

RxCUI
1100075
UNII
EM5OCB9YJ6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abiraterone acetate (source: ndc)
Generic Name abiraterone acetate (source: ndc)
Application Number ANDA208453 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 CARTON (0904-6948-04) / 1 TABLET in 1 BLISTER PACK
source: ndc

Packages (1)

0904-6948-04 30 BLISTER PACK in 1 CARTON (0904-6948-04) / 1 TABLET in 1 BLISTER PACK

Ingredients (1)

abiraterone acetate (250 mg/1)

Linked Drug Pages (1)

Abiraterone Acetate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d8b7c351-b030-4655-94af-f88ad6c5bd12", "openfda": {"unii": ["EM5OCB9YJ6"], "rxcui": ["1100075"], "spl_set_id": ["49809a29-6558-43a3-a347-5027de44aa41"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0904-6948-04)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "0904-6948-04", "marketing_start_date": "20181123"}], "brand_name": "Abiraterone Acetate", "product_id": "0904-6948_d8b7c351-b030-4655-94af-f88ad6c5bd12", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "0904-6948", "generic_name": "Abiraterone Acetate", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone Acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208453", "marketing_category": "ANDA", "marketing_start_date": "20181123", "listing_expiration_date": "20261231"}